ArticleBMC cancer2025

Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.

Georgia Anguera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.